Skip to main content
. 2022 Jul 15;101(28):e29577. doi: 10.1097/MD.0000000000029577

Figure 1.

Figure 1.

Flow chart showing individuals included in the analysis. The first analysis focused on determining the prevalence of low-frequency drug resistance mutations. The second analysis only used participants with follow-up viral load data to assess the impact of low-frequency drug resistance mutations on virological outcomes. DRM, drug resistance mutations; NGS, next-generation sequencing.